SDY1640: T and B cell responses to SARS-CoV-2 coronavirus. Grifoni, et al., Cell, Jun 2020 New release - February 2020
SDY1641: Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension. Meng et al., Emerging Microbes and Infections, Dec 2020
SDY1648: Sex differences in immune responses to SARS-CoV-2 (Companion study to SDY1655). Takahashi et al., Nature, Aug 2020
SDY1655: Longitudinal Analyses Reveal Immunological Misfiring in Severe COVID-19. Lucas et al., Nature, Aug 2020
SDY1662: An Inflammatory Cytokine Signature Predicts Covid-19 Severity And Survival. del Valle et al., Nature Medicine, Oct 2020
SDY1667: Cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Mateus et al., Science, Oct 2020. New release - February 2020
SDY1680: T cell and antibody functional correlates of severe COVID-19.
Click on a study number for more information